Navigation Links
The Leukemia & Lymphoma Society and Celator Pharmaceuticals Announce Partnership to Accelerate Development of CPX-351 for AML
Date:1/22/2009

WHITE PLAINS, N.Y. and PRINCETON, N.J., Jan. 22 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) and Celator Pharmaceuticals, Inc. today announced a partnership to support Phase 2 development of Celator's lead product candidate CPX-351 (Cytarabine:Daunorubicin) Liposome Injection for treatment of adults with acute myeloid leukemia (AML).

Through the partnership, LLS will provide $3.7 million to support Celator's Phase 2B multicenter, randomized, open-label trial of CPX-351 versus intensive salvage therapy in adult patients less than or equal to 60 years of age with AML in first relapse. Celator expects to start patient enrollment in this study in the first quarter of 2009 in the United States and Canada.

The partnership between Celator and LLS is part of LLS's Therapy Acceleration Program (TAP), which supports private sector and academic-based projects with the goal of advancing investigational therapies with high prospects for providing near-term benefit to patients with blood cancers.

"Celator has discovered a novel way to deliver and enhance the activity of agents that have been the standard of care in AML for decades," said Louis DeGennaro, Ph.D., LLS's chief scientific officer. "There have been many attempts to improve outcomes in this patient population with little success. The data collected on CPX-351 to date, and the enthusiasm of clinical investigators involved in that research, suggest that Celator's approach holds real promise to advance the treatment of AML."

"We are very pleased that The Leukemia & Lymphoma Society sees the potential of CPX-351 and is making this substantial investment," said Scott Jackson, chief executive officer, Celator Pharmaceuticals. "LLS has created a well defined, streamlined process for accessing capital for promising new blood cancer treatments. This commitment enhances our ability to further the clinical development of CPX-351
'/>"/>

SOURCE Celator Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
2. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
3. St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia
4. September is Leukemia, Lymphoma and Myeloma Awareness Month
5. The Leukemia & Lymphoma Society is Encouraged by Promising News for Myeloma Patients
6. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
7. Leukemia Drug Proves Safe and Effective Over the Long Term
8. TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
9. Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML)
10. Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients
11. Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... de agosto de 2015   Royal Philips ... en el  Congreso de la ESC de 2015 ... y novedosas, entre ellas HeartModel A.I.  , EchoNavigator ... y la tecnología con los protocolos de atención ... tratamientos y permitir atención en el hogar. ...
(Date:8/27/2015)... 27, 2015 DURECT Corporation (Nasdaq: DRRX ... at three upcoming healthcare conferences.  , ... present at the Rodman & Renshaw Investment Conference on ... conference is being held at the St. Regis Hotel ... live audio webcast of the presentation will be available ...
(Date:8/27/2015)... MEETING, Pa. , Aug. 27, 2015  Now ... decommissioning the Da Vinci S™ surgical robot, hospitals with ... replacement plans. They also need to see where they ... procedures on the right patients? Have they adopted best ... robotic surgery program in the future? ECRI ...
Breaking Medicine Technology:Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5DURECT to Participate in Upcoming Healthcare Conferences 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 3
... Rcadia Medical Imaging has achieved proof-of-concept with the first ... a coronary CT angiography (cCTA) study. This technology, the ... scoring, has the potential to eliminate the need for ... costs  and decrease patient radiation exposure. This work in ...
... The Renal Therapies Division of B. ... of the Plasmat™ Futura System for H.E.L.P. ®   ... H.E.L.P. ® therapy provides a more easy-to-use system ... patients with severe hypercholesterolemia. (Logo: http://photos.prnewswire.com/prnh/20081022/NYW008LOGO) ...
Cached Medicine Technology:Rcadia's Fully Automatic Calcium Score Assessment from Coronary CTA Shows Potential to Eliminate Need for Separate Scan 2B. Braun Renal Therapies Division Announces Availability of Advanced Apheresis Therapy System 2
(Date:8/28/2015)... ... August 28, 2015 , ... Healthpointe clinics throughout ... go deep sea diving. The act of recreational diving exposes the body ... reasons, it is vital that all recreational and professional divers undergo regular comprehensive ...
(Date:8/28/2015)... , ... August 28, 2015 ... ... Inc.’s (AIS) Medicare-Medicaid Dual Eligibles Database have added comprehensive information on two ... demonstration approved for a December 2015 launch; and Idaho’s partnership to revamp ...
(Date:8/28/2015)... ... August 28, 2015 , ... External Counterpulsation, also known as ECP or EECP, ... External Counterpulsation (EECP or ECP) machines with a full clinic licence to help people ... since 2007 helping people prevent and reverse heart disease through its evidence-based ...
(Date:8/28/2015)... ... August 28, 2015 , ... A complimentary webinar offered by healthcare ... Medicaid Services’ (CMS) proposal to mandate bundled payments through the Comprehensive Care ... for Game Day: Comprehensive Care for Joint Replacement,” takes place at 12 noon EDT ...
(Date:8/28/2015)... ... August 28, 2015 , ... An independent study ... in high percentages of change to treatment recommendations and diagnosis. The 2015 return ... Tennessee Tech University and analyzed WorldCare’s second opinion process. , The study reviewed ...
Breaking Medicine News(10 mins):Health News:Healthpointe Now Offering Scuba Physicals 2Health News:AIS Duals Database: August Update Finds Two New Duals Programs in Rhode Island and Idaho 2Health News:Buy New External Counterpulsation (EECP or ECP) With Heart Fit Clinic 2Health News:PYA Offers Complimentary CCJR Webina — Game On 2Health News:PYA Offers Complimentary CCJR Webina — Game On 3Health News:WorldCare International, Inc. Celebrates Findings of Independent ROI Study 2
... Society of,Transplantation (AST) is hitting the road to spread ... -- human resource professionals., AST is scheduled to ... Management (SHRM) nationwide to promote the Society,s Employee,Leave and ... to adopt paid leave policies for employees who act ...
... deliver healthcare to patients is key to ensuring that Medicare ... boomers according to a new paper by Geisinger Health System ... as the paper points out, is that the solutions are ... develop financial incentives that reward providers when better care is ...
... natural sweet defeats the bacteria that drive the ailment, ... Honey may help bring sweet relief to chronic sinusitis ... germ fighters in honey attack the bacteria that cause ... traditional medicine as a natural anti-microbial dressing for infected ...
... 24 For the first time, accumulated ... cancer, especially,ovarian and uterine (endometrial) cancers, experience ... oncologist. The 2008 State of the State,of ... Women of America,published by the Gynecologic Cancer ...
... Workers Struggle to Improve Care for the Sick & Elderly ... Facilities Owned By ... 700 healthcare,workers began a two-day unfair labor practice strike Wednesday ... delivery of patient care to hundreds of sick and elderly ...
... DIEGO, Sept. 24 The World Privacy ... Requirements: Suggestions for,Health Care Providers, discusses the ... health care sector along with suggestions for ... the Federal Trade,Commission that require financial institutions ...
Cached Medicine News:Health News:AST to Address Human Resources Groups Nationwide to Encourage them to Adopt a Paid Leave Plan for Organ Donors 2Health News:Geisinger study: Increasing health care value improves health care quality 2Health News:A Honey of a Sinusitis Treatment 2Health News:A Honey of a Sinusitis Treatment 3Health News:Ovarian and Endometrial Cancer Patients Experience Improved Outcomes When Treated First by a Gynecologic Oncologist 2Health News:Ovarian and Endometrial Cancer Patients Experience Improved Outcomes When Treated First by a Gynecologic Oncologist 3Health News:Caregivers Hold Unfair Labor Practice Strike to Improve Quality of Resident Care at Statewide Nursing Home Chain 2Health News:Caregivers Hold Unfair Labor Practice Strike to Improve Quality of Resident Care at Statewide Nursing Home Chain 3Health News:(Report) World Privacy Forum Publishes Red Flag Rule Suggestions for Hospitals and Providers; New FTC-Enforced Rules Go Into Effect Nov. 1, Can Apply to Health Care Providers 2
... multimode readers offering 96-channel parallel detection of ... and 1,536-well microtiter plates. Compact workstations ... for the transport of microtiter plates with ... day. The need for mechanical switching required ...
Easy to use , Allow for a flexible washing , Uniform and efficient , Very robust and reliable , Adjustable to all well shapes , Rack included (not autoclavable) , Autoclavable at 121C , No e...
... Embla microplate washers available to ... most cell-based assays. Embla 384 ... that have been optimized to ... are robotic compatible and have ...
Space-saving counter top model,User initiated manual defrost,Standard features (see above),Internal freezing compartment,Removable half-shelf in refrigerator,Two shelves in door,UL 471 Commercial Ref...
Medicine Products: